Compare RSI & PGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RSI | PGEN |
|---|---|---|
| Founded | 2012 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Services-Misc. Amusement & Recreation | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8B | 1.6B |
| IPO Year | 2020 | 2013 |
| Metric | RSI | PGEN |
|---|---|---|
| Price | $20.53 | $3.26 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 8 | 5 |
| Target Price | ★ $22.75 | $7.67 |
| AVG Volume (30 Days) | 2.3M | ★ 4.7M |
| Earning Date | 05-21-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 933.33 | N/A |
| EPS | ★ 0.31 | N/A |
| Revenue | ★ $1,134,428,000.00 | $230,981,000.00 |
| Revenue This Year | $25.00 | $342.78 |
| Revenue Next Year | $13.89 | $478.46 |
| P/E Ratio | $67.32 | ★ N/A |
| Revenue Growth | ★ 22.76 | N/A |
| 52 Week Low | $9.54 | $1.11 |
| 52 Week High | $22.65 | $5.47 |
| Indicator | RSI | PGEN |
|---|---|---|
| Relative Strength Index (RSI) | 67.10 | 31.85 |
| Support Level | $16.41 | $2.99 |
| Resistance Level | $22.55 | $5.10 |
| Average True Range (ATR) | 0.96 | 0.32 |
| MACD | 0.30 | -0.12 |
| Stochastic Oscillator | 92.17 | 2.45 |
Rush Street Interactive Inc is an online gaming and entertainment company that focuses on online casinos and online sports betting in the U.S. and Latin American markets. It provides customers with an array of gaming offerings such as real-money online casinos, online sports betting, and retail sports betting, as well as social gaming, which involves free-to-play games that use virtual credits that can be earned or purchased. The company generates revenue by offering online casinos, online sports betting, and social gaming directly to the end customer through its websites or apps. The company generates revenue through business-to-consumer (B2C) and business-to-business (B2B) models.
Precigen Inc is a biotechnology company that develops synthetic biology solutions. The company designs build and regulate gene programs. Its technologies are broadly applicable across a wide range of diverse end markets. Intrexon's business model is to commercialize its technologies through exclusive channel collaborations with collaborators that have specific industry expertise, development resources, and sales and marketing capabilities, in order to bring new and improved products and processes to market. Its reportable segments are Biopharmaceuticals and Exemplar. The company's collaborators provide compensation through technology access fees, royalties, milestones, and reimbursement of certain costs.